NAXEN Trademark

Trademark Overview

On Tuesday, March 7, 2023, a trademark application was filed for NAXEN with the United States Patent and Trademark Office. The USPTO has given the NAXEN trademark a serial number of 97826532. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, September 4, 2024. This trademark is owned by IPS Trust. The NAXEN trademark is filed in the Pharmaceutical Products category with the following description:

Pain relief medication
naxen

General Information

Serial Number97826532
Word MarkNAXEN
Filing DateTuesday, March 7, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and ServicesPain relief medication

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPS Trust
Party Type20 - Owner at Publication
Legal Entity Type17 - Trust
AddressArlington, VA 22201
Party NameIPS Trust
Party Type10 - Original Applicant
Legal Entity Type17 - Trust
AddressArlington, VA 22201

Trademark Events

Event DateEvent Description
Friday, March 10, 2023NEW APPLICATION ENTERED
Monday, March 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 5, 2023ASSIGNED TO EXAMINER
Wednesday, December 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 26, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, September 4, 2024SOU EXTENSION 1 GRANTED
Wednesday, September 4, 2024SOU EXTENSION 1 FILED

Related Keywords

naxen medication relief pain